Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI generations. - Cooper R; Ramaswami D; Thomas JS; Nieva JJ; Hsu R (Discover oncology, 2024)